IP Verse

Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease - EP3009143B1

PatentPatent Analysis

EP3009143

NEURODYN LIFE SCIENCES
Application Number
EP15194111A
Filing Date
Jan 16, 2009
Status
Revoked
Jul 7, 2023
Grant Date
Oct 3, 2018
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3009143B1 was granted to Neurodyn Life Sciences on Oct 3, 2018 following the initial filing on Jan 16, 2009 under the application number EP15194111A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CMS CAMERON MCKENNA NABARRO OLSWANGJul 3, 2019ADMISSIBLE
MATHYS & SQUIREJul 2, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents